Loading organizations...
VP Venture Partners is a private venture capital firm based in Zurich, Switzerland, dedicated to investing in early-stage life science companies across Europe. The firm provides capital and strategic support, focusing specifically on human life sciences to foster the development of innovative solutions within the sector. Their methodology emphasizes close collaboration with founders and active guidance for their portfolio companies, aiming to optimize their path to market and sustained growth.
Founded in 2020 by Dr. Valentin Piëch, the firm emerged from an understanding of the critical need for specialized early-stage funding and operational mentorship within the European life science ecosystem. Dr. Piëch established the venture to bridge this gap, leveraging a targeted investment strategy to identify and nurture promising biomedical and biotechnology enterprises from their foundational stages. This strategic focus enables the firm to cultivate a portfolio aligned with significant industry advancements.
The firm's clientele primarily consists of nascent European companies operating at the forefront of human life sciences. VP Venture Partners’ long-term vision is to serve as a pivotal growth engine for these ventures, enabling them to translate scientific breakthroughs into tangible healthcare improvements. They aim to contribute significantly to the future landscape of life science innovation through informed investment and sustained partnership.
VP%20Venture%20Partners has 3 tracked investments across 3 companies. The latest tracked deal is $3.0M Seed in aTENSION.life in May 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 7, 2025 | aTENSION.life | $3.0M Seed | Werner Lanthaler | Eqventure |
| Apr 26, 2022 | Hemotune | $7.6M Series B | Cedric Barra | Hemex, Zürcher Kantonalbank |
| Jun 1, 2020 | Allcyte | $6.0M Seed | AIR Street Capital, Amino Collective, 42CAP, Push Ventures, Vp%20venture%20partners | Band OF Angels, Bornschein & Keine Töchter, Philipp Herkelmann |